TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation

TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation

Conditions: Hypogonadism, Male; End Stage Renal Disease (ESRD); Kidney Transplant
Interventions: Drug: Testosterone Replacement Therapy
Sponsors: University of California, Los Angeles
Active, not **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 18, 2025Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments